Psychotropic medications in mood disorders: to deprescribe or not?

The British Journal of Psychiatry 2026 Open access

Read full text
Authors: Jeffrey CL Looi, Erica Bell, Steve R Kisely, Kinga Szymaniak, Gurubhaskar Shivakumar, Anne Naylor, Joseph F. Goldberg, Gin S. Malhi
DOI: 10.1192/bjp.2026.10779
Cited by: 1
References: 8

Abstract

In recent years deprescribing mood disorder medications has attracted increasing attention, and guidance provides suggestions for clinical implementation of deprescribing strategies that have been derived through expert consensus. Summarising and highlighting key recommendations, we discuss their execution in various clinical contexts and discuss their integration into clinical practice.

Fields of Study & Subjects

Treatment of Major Depression Bipolar Disorder and Treatment Attention Deficit Hyperactivity Disorder

Publication details

Journal / source
The British Journal of Psychiatry
Publisher
Royal College of Psychiatrists
Pages
1–5
Publication date
14 September 2026
Language
EN